• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Predicting Mortality for Patients Eligible for Extracorporeal Membrane Oxygenation for COVID-19.

作者信息

Gannon Whitney D, Stokes John W, Gong Wu, Lindsell Christopher J, Tonna Joseph E, Bacchetta Matthew, Rice Todd W, Semler Matthew W, Casey Jonathan D

机构信息

Vanderbilt University Medical Center Nashville, Tennessee.

University of Utah Health Salt Lake City, Utah.

出版信息

Am J Respir Crit Care Med. 2022 Sep 1;206(5):628-632. doi: 10.1164/rccm.202202-0237LE.

DOI:10.1164/rccm.202202-0237LE
PMID:35549663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9716900/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b723/9716900/1ed52b486fab/rccm.202202-0237LEf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b723/9716900/1ed52b486fab/rccm.202202-0237LEf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b723/9716900/1ed52b486fab/rccm.202202-0237LEf1.jpg

相似文献

1
Predicting Mortality for Patients Eligible for Extracorporeal Membrane Oxygenation for COVID-19.预测符合COVID-19体外膜肺氧合治疗条件患者的死亡率
Am J Respir Crit Care Med. 2022 Sep 1;206(5):628-632. doi: 10.1164/rccm.202202-0237LE.
2
Extracorporeal membrane oxygenation for COVID-19: Some answers and a remaining question.用于治疗新型冠状病毒肺炎的体外膜肺氧合：一些答案与一个遗留问题。
Anaesth Crit Care Pain Med. 2022 Feb;41(1):100986. doi: 10.1016/j.accpm.2021.100986. Epub 2021 Nov 25.
3
Extracorporeal Membrane Oxygenation with Right Ventricular Assist Device for COVID-19 ARDS.体外膜肺氧合联合右心室辅助装置治疗 COVID-19 相关急性呼吸窘迫综合征。
J Surg Res. 2021 Aug;264:81-89. doi: 10.1016/j.jss.2021.03.017. Epub 2021 Mar 18.
4
Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study.体外膜肺氧合治疗 2019 冠状病毒病所致急性呼吸窘迫综合征：一项多中心描述性研究。
Crit Care Med. 2020 Sep;48(9):1289-1295. doi: 10.1097/CCM.0000000000004447.
5
Turning the Page on Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome due to Severe COVID-19.告别严重新型冠状病毒肺炎所致急性呼吸窘迫综合征的体外膜肺氧合治疗
Am J Respir Crit Care Med. 2022 Aug 1;206(3):236-239. doi: 10.1164/rccm.202205-0906ED.
6
Characteristics and Outcome of Patients After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome.接受体外膜肺氧合治疗急性呼吸窘迫综合征的异基因造血干细胞移植患者的特征及预后
Crit Care Med. 2017 May;45(5):e500-e507. doi: 10.1097/CCM.0000000000002293.
7
Association between Availability of Extracorporeal Membrane Oxygenation and Mortality in Patients with COVID-19 Eligible for Extracorporeal Membrane Oxygenation: A Natural Experiment.体外膜肺氧合可用性与符合体外膜肺氧合治疗标准的COVID-19患者死亡率之间的关联：一项自然实验。
Am J Respir Crit Care Med. 2022 Jun 1;205(11):1354-1357. doi: 10.1164/rccm.202110-2399LE.
8
Extracorporeal Membrane Oxygenation for Patients With COVID-19 in Severe Respiratory Failure.体外膜肺氧合治疗 COVID-19 合并严重呼吸衰竭患者。
JAMA Surg. 2020 Oct 1;155(10):990-992. doi: 10.1001/jamasurg.2020.3950.
9
Improving Outcomes for Patients With Severe COVID-19 Acute Respiratory Distress Syndrome Supported With Extracorporeal Membrane Oxygenation.改善接受体外膜肺氧合支持的重症新型冠状病毒肺炎急性呼吸窘迫综合征患者的预后
Ann Thorac Surg. 2023 Apr;115(4):1086-1087. doi: 10.1016/j.athoracsur.2022.06.025. Epub 2022 Jul 3.
10
Individualized positive end-expiratory pressure setting in patients with severe acute respiratory distress syndrome supported with veno-venous extracorporeal membrane oxygenation.在接受静脉-静脉体外膜肺氧合支持的严重急性呼吸窘迫综合征患者中进行个体化的呼气末正压设置。
Perfusion. 2021 May;36(4):374-381. doi: 10.1177/0267659120946728. Epub 2020 Aug 10.

引用本文的文献

1
Lung Transplant Success in COVID-19 Patients Requiring V-V ECMO: One-Year Follow-Up.需要静脉-静脉体外膜肺氧合的新冠肺炎患者肺移植成功：一年随访
Ann Transplant. 2024 Dec 24;29:e946088. doi: 10.12659/AOT.946088.
2
Outcomes of Severe ARDS COVID-19 Patients Denied for Venovenous ECMO Support: A Prospective Observational Comparative Study.被拒绝接受静脉-静脉体外膜肺氧合支持的重症新型冠状病毒肺炎急性呼吸窘迫综合征患者的结局：一项前瞻性观察性比较研究
J Clin Med. 2024 Mar 5;13(5):1493. doi: 10.3390/jcm13051493.
3
Relationship between the Pre-ECMO and ECMO Time and Survival of Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Respiratory ECMO Survival Prediction (RESP) Score for COVID-19 Patients Treated with ECMO.用于 COVID-19 患者 ECMO 治疗的呼吸 ECMO 生存预测（RESP）评分。
ASAIO J. 2022 Apr 1;68(4):486-491. doi: 10.1097/MAT.0000000000001640.
2
Treating the Most Critically Ill Patients With COVID-19: The Evolving Role of Extracorporeal Membrane Oxygenation.治疗新冠肺炎危重症患者：体外膜肺氧合的角色演变
JAMA. 2022 Jan 4;327(1):31-32. doi: 10.1001/jama.2021.22580.
3
Extracorporeal Membrane Oxygenation Support for Influenza A: Retrospective Review of the Extracorporeal Life Support Organization Registry Comparing H1N1 With Other Subtypes.
体外膜肺氧合（ECMO）治疗前时间和ECMO治疗时间与重症新型冠状病毒肺炎（COVID-19）患者生存的关系：一项系统评价和荟萃分析
J Clin Med. 2024 Feb 1;13(3):868. doi: 10.3390/jcm13030868.
甲型流感的体外膜肺氧合支持：对体外生命支持组织登记处的回顾性研究，比较H1N1与其他亚型
Crit Care Explor. 2021 Dec 9;3(12):e0598. doi: 10.1097/CCE.0000000000000598. eCollection 2021 Dec.
4
Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study.体外膜肺氧合网络组织与 COVID-19 大流行期间法国大巴黎地区的临床结局：一项多中心队列研究。
Lancet Respir Med. 2021 Aug;9(8):851-862. doi: 10.1016/S2213-2600(21)00096-5. Epub 2021 Apr 19.
5
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry.COVID-19 患者的体外膜肺氧合支持：体外生命支持组织登记处的国际队列研究。
Lancet. 2020 Oct 10;396(10257):1071-1078. doi: 10.1016/S0140-6736(20)32008-0. Epub 2020 Sep 25.
6
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.透明报告个体预后或诊断的多变量预测模型（TRIPOD）：解释和说明。
Ann Intern Med. 2015 Jan 6;162(1):W1-73. doi: 10.7326/M14-0698.
7
Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score.体外膜肺氧合治疗严重急性呼吸衰竭患者的预后预测。呼吸体外膜肺氧合生存预测（RESP）评分。
Am J Respir Crit Care Med. 2014 Jun 1;189(11):1374-82. doi: 10.1164/rccm.201311-2023OC.
8
The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome.体外膜肺氧合治疗严重急性呼吸窘迫综合征的 PRESERVE 死亡率评分和长期预后分析。
Intensive Care Med. 2013 Oct;39(10):1704-13. doi: 10.1007/s00134-013-3037-2. Epub 2013 Aug 2.
9
pROC: an open-source package for R and S+ to analyze and compare ROC curves.pROC：一个用于 R 和 S+的开源软件包，用于分析和比较 ROC 曲线。
BMC Bioinformatics. 2011 Mar 17;12:77. doi: 10.1186/1471-2105-12-77.